Powered by Hyperliquid
hello@perplo.app
$0.00000.00%
$0.0000
0.00%
UTC
PriceSizeTotal

About Eli Lilly and Company

IndustryPharmaceuticals
CountryUS
ExchangeNYSE
IPO dateJul 9, 1970
Websitewww.lilly.com

Key financials

P/E ratio
48.38
EPS (TTM)
$30.81
Beta
0.39
Dividend yield
0.75%
Shares out.
940.75M

Analyst ratings

11
Strong buy
21
Buy
4
Hold
1
Sell
0
Strong sell
37 analysts

Earnings history

Recent news

Recent moves

All LLY moves
  • +1.87%
    Oct 31

    Raised outlook sends Lilly to a record high

  • +6.46%
    Oct 30

    Raised FY guidance after strong Q3 beat

  • +6.36%
    Oct 29

    Raised FY guidance after strong Q3 beat

  • −3.25%
    Oct 1

    Mixed obesity trial data weighs on pipeline outlook

Market

LLY right now

The US stock market is closed before the 09:30 ET open. LLY perpetual futures are still trading. The perp market runs 24/7, so the price below is live rather than a stale close.

Price
$1,404.00
24h
−0.95%
Funding (1h)
+0.0023%
Open interest
$5.9M
24h volume
$2.3M
Max leverage
10×

Snapshot as of 06:52 UTC. The chart and price above update live. Machine-readable version.

How it trades

Trading Eli Lilly on Perplo

Obesity drugs (GLP-1). Perplo lists it as a perpetual future: you trade the price of Eli Lilly, not the share itself.

There is no expiry and no market-hours window — LLY trades 24/7. You post USDC as collateral, take either side with leverage, and settle onchain on Hyperliquid. No brokerage account.

Theme

More in Healthcare & Biotech

  • HIMSHims & Hers
  • MRNAModerna
  • XBISPDR Biotech ETF
  • TWSTTwist Bioscience